Armstrong Advisory Group »

Bioxcel Therapeutics shares owned by Armstrong Advisory Group

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Armstrong Advisory Group from 13F filings

Historical chart of Armstrong Advisory Group investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Armstrong Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Armstrong Advisory Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.0k 1.0k 2.95
2023-12-31 $3.0k 1.0k 2.95
2023-09-30 $2.5k 1.0k 2.53
2023-06-30 $8.0k 1.2k 6.66
2023-03-31 $19k 1.0k 18.66
2022-12-31 $22k 1.0k 21.48

More positions owned by Armstrong Advisory Group

Ishares Tr 7-10 Yr Trsy Bd (IEF)
Vanguard World Fds Inf Tech Etf (VGT)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Schwab Strategic Tr 1000 Index Etf (SCHK)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard World Fds Health Car Etf (VHT)
Select Sector Spdr Tr Financial (XLF)
Ishares Tr Core S&p500 Etf (IVV)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Ishares Tr Us Treas Bd Etf (GOVT)
Ishares Tr 3 7 Yr Treas Bd (IEI)
Vanguard World Fds Comm Srvc Etf (VOX)
Vanguard Index Fds Extend Mkt Etf (VXF)
Select Sector Spdr Tr Indl (XLI)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)

View all positions for Armstrong Advisory Group

Top funds holding Bioxcel Therapeutics

Vanguard Group
Beacon Pointe Advisors
Charles Schwab Investment Management
Citadel Advisors
Bank of New York Mellon
Arete Wealth Advisors
Bank of America Corporation
Bank Of Montreal
Millennium Management
Wells Fargo & Company
Virtu Financial
Squarepoint Ops
Tocqueville Asset Management
UBS Group
D. E. Shaw & Co

View all funds holding Bioxcel Therapeutics